by Elana Gotkine For patients with severe eosinophilic asthma controlled on bevacizumab, tapering of inhaled corticosteroids (ICS) is feasible and is not associated with worse asthma control, according to a study published online on Dec. 7 in The Lancet. David J. Jackson, M.P.H., from King’s College London, and colleagues conducted a phase 4 study involving...
